Effects of a high proportion of cefoperazone/tazobactam on lung function and bacterial clearance rate in patients with chronic obstructive pulmonary disease and lower respiratory tract infection Klebsiella pneumoniae

In the treatment of COPD patients with lower respiratory tract infection Klebsiella pneumoniae, intravenous infusion of cefoperazone/tazobactam in a proportion of 8: 1 is a better treatment plan. High-proportion intravenous infusion of cefoperazone/tazobactam can quickly restore the patient's lung function and is more effective in improving treatment efficiency and bacterial clearance rate.